Scanagati O O
then O O
recommended O O
the O O
continuation O O
of O O
the O O
electuary O O
made O O
of O O
emollient O O
, O O
guaiacum O O
resin O O
, O O
balsam O O
, O O
rhubarb B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
and O O
nitre O O
. O O

Either O O
Lipofectin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
( O O
Invitrogen O B_PROTEIN[GENE]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
or O O
Effectene O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
transfection O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
reagent O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
Qiagen O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
was O O
used O O
for O O
the O O
transfection O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Patients B B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
and O O
sera O O

It O O
focuses O O
on O O
the O O
endocrine O O
cell O O
- O O
to O O
- O O
cell O O
communication O O
and O O
enables O O
the O O
analysis O O
of O O
intercellular O O
regulatory O O
pathways O O
in O O
humans B B_DISEASE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

In O O
the O O
EndoNet O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_EDU[ORGANIZATION]
data O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_EDU[ORGANIZATION]
model O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_EDU[ORGANIZATION]
, O O
two O B_LOCATION/B_MEASURE
classes O I_LOCATION/I_MEASURE
of O O
components O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
span O O
a O O
bipartite O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
directed O O
graph O B_LOCATION
. O O

Intercellular O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
signaling O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
is O O
addressed O O
only O O
insofar O O
as O O
usually O O
the O O
pathways O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_GENE
modeled O O
start O B_LOCATION/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
with O O
extracellular O B_BIO/B_GENE
ligands O I_BIO/I_GENE
, O O
and O O
as O O
there O O
exist O O
catalogs O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANIZATION
and O O
databases O B_ORGANIZATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
about O O
secreted O B_GENE/B_LOCATION
proteins O I_GENE/I_LOCATION
, O O
or O O
the O O
' O O
secretome O B_BACTERIUM[BIO]/B_LOCATION
' O O
, O O
of O O
certain O B_GENE/B_BIO
systems O I_GENE/I_BIO
( O O
9 O B_NUMBER[MEASURE]
- O O
12 O B_MEASURE
) O O
. O O

Table O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
4 O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
also O O
shows O O
the O O
number O B_MEASURE
of O O
polymorphisms O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
exclusive O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
for O O
each O O
species O B_BIO/B_GENE
( O O
Sint O B_LOCATION/B_PERSON
and O O
Swhit O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
) O O
, O O
the O O
number O B_MEASURE
of O O
shared O O
polymorphisms O B_GENE
( O O
Ss O B_LOCATION
) O O
and O O
the O O
number O B_MEASURE/B_LOCATION
of O O
fixed O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
differences O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
( O O
Sf O B_PROTEIN[GENE]/B_LOCATION
) O O
between O O
species O B_BIO/B_GENE
. O O

Fig O O
5 O O
shows O O
the O O
posterior O O
distributions O O
for O O
migration O O
rates O O
and O O
reveals O O
a O O
null O O
probability O O
for O O
the O O
absence O O
of O O
migration O O
from O O
L B B_BIO/B_LOCATION
. I I_BIO/I_LOCATION
whitmani I I_BIO/I_LOCATION
towards O O
L B B_LOCATION
. I I_LOCATION
intermedia I I_LOCATION
. O O

Alexa O O
Fluor O O
647 O O
- O O
conjugated O O
mouse B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
IgG1 O O
( O O
BD O O
Biosciences O O
) O O
was O O
used O O
as O O
an O O
isotype O O
control O O
. O O

There O O
is O O
also O O
an O O
increase O O
in O O
sympathetic O O
neuron O O
cell O O
death O O
in O O
TrkA O O
knockout O O
mice B B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
[ O O
12 O O
] O O
. O O

In O O
the O O
superior O O
cervical O O
ganglion O O
, O O
an O O
increase O O
in O O
the O O
number O O
of O O
neurons O O
of O O
BDNF O O
null O O
mice B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
is O O
likely O O
due O O
to O O
apoptosis O O
induced O O
by O O
BDNF O O
via O O
p75NTR O O
[ O O
18 O O
] O O
. O O

Primary O O
antibodies O O
used O O
were O O
: O O
rabbit B B_SPECIES[BIO]/B_GENE
anti O O
- O O
p75 O O
( O O
1 O O
: O O
1500 O O
, O O
generous O O
gift O O
from O O
Louis O O
Reichardt O O
, O O
UCSF O O
[ O O
26 O O
] O O
) O O
, O O
mouse B B_SPECIES[BIO]/B_DISEASE
IgG2b O O
anti O O
- O O
Hu O O
C O O
/ O O
D O O
, O O
( O O
1 O O
: O O
250 O O
, O O
Molecular O O
Probes O O
) O O
; O O
mouse B B_SPECIES[BIO]/B_DISEASE
IgG1 O O
anti O O
- O O
Islet O O
- O O
1 O O
, O O
( O O
1 O O
: O O
10 O O
, O O
Developmental O O
Studies O O
Hybridoma O O
Bank O O
) O O
; O O
rabbit B B_SPECIES[BIO]
anti O O
- O O
chicken B B_SPECIES[BIO]
TrkA O O
( O O
1 O O
: O O
500 O O
) O O
; O O
rabbit B B_SPECIES[BIO]
anti O O
- O O
chicken B B_SPECIES[BIO]
TrkB O O
( O O
1 O O
: O O
500 O O
) O O
; O O
rabbit B B_SPECIES[BIO]
anti O O
- O O
chicken B B_SPECIES[BIO]
TrkC O O
( O O
1 O O
: O O
500 O O
) O O
( O O
all O O
Trk O O
antibodies O O
were O O
generous O O
gifts O O
of O O
Dr O O
. O O
Louis O O
Reichardt O O
, O O
UCSF O O
[ O O
26 O O
- O O
28 O O
] O O
) O O
; O O
mouse B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
anti O O
- O O
HNK O O
- O O
1 O O
( O O
1 O O
: O O
50 O O
, O O
Developmental O O
Studies O O
Hybridoma O O
Bank O O
) O O
; O O
mouse B B_DISEASE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
IgG2a O O
anti O O
- O O
tyrosine O O
hydroxylase O O
( O O
1 O O
: O O
10 O O
, O O
Developmental O O
Studies O O
Hybridoma O O
Bank O O
) O O
, O O
sheep B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SPECIES[BIO]
anti O O
- O O
BrdU O O
( O O
1 O O
: O O
100 O O
, O O
Biodesign O O
International O O
) O O
, O O
rabbit B B_MEASURE
anti O O
- O O
tyrosine O O
hydroxylase O O
( O O
1 O O
: O O
100 O O
, O O
Chemicon O O
) O O
, O O
and O O
goat B B_SPECIES[BIO]/B_LOCATION
anti O O
- O O
TrkB O O
( O O
1 O O
: O O
1000 O O
, O O
R O O
& O O
D O O
Systems O O
) O O
. O O

New O O
video O O
analysis O O
of O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
Woodpeckers I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
in O O
escape O O
flights O O
comparable O O
to O O
that O O
of O O
the O O
putative O O
Ivory B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
filmed O O
in O O
Arkansas O O
shows O O
that O O
Pileated B B_PERSON/B_BIO
Woodpeckers I I_PERSON/I_BIO
can O O
display O O
a O O
wingbeat O O
frequency O O
equivalent O O
to O O
that O O
of O O
the O O
Arkansas O O
bird O O
during O O
escape O O
flight O O
. O O

Crucial O O
to O O
the O O
scientific O O
case O O
for O O
the O O
persistence O O
of O O
the O O
Ivory B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
- I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
billed I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
Woodpecker I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE
was O O
a O O
4 O O
s O O
video O O
of O O
a O O
large O O
woodpecker O O
in O O
flight O O
recorded O O
by O O
M O O
. O O
D O O
. O O

This O O
study O O
was O O
undertaken O O
to O O
determine O O
whether O O
the O O
flight O O
and O O
plumage O O
of O O
the O O
bird O O
in O O
the O O
Luneau O O
video O O
really O O
was O O
inconsistent O O
with O O
either O O
a O O
normal O O
or O O
partial O O
albino O O
Pileated B B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
Woodpecker I I_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

Independent O O
analyses O O
of O O
the O O
plumage O O
patterns O O
and O O
wingbeat O O
frequencies O O
observable O O
in O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
Woodpeckers I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
are O O
presented O O
, O O
and O O
it O O
is O O
concluded O O
that O O
the O O
identification O O
of O O
the O O
bird O O
in O O
the O O
Luneau O O
video O O
as O O
definite O O
Ivory B B_BIO/B_PERSON
- I I_BIO/I_PERSON
billed I I_BIO/I_PERSON
Woodpecker I I_BIO/I_PERSON
is O O
probably O O
unsafe O O
. O O

Four O O
escape O O
flights O O
were O O
captured O O
that O O
approximate O O
to O O
that O O
recorded O O
for O O
the O O
putative O O
Ivory B B_TIME[MEASURE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I B_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I B_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I B_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Campephilus B B_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
principalis I B_TIME[MEASURE]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
by O O
Luneau O O
in O O
April O O
2004 O O
and O O
published O O
in O O
Fitzpatrick O O
et O O
al O O
[ O O
1 O O
] O O
. O O

The O O
8 O O
. O O
6 O O
beats O O
s O O
- O O
1 O O
of O O
the O O
bird O O
identified O O
in O O
the O O
Luneau O O
video O O
, O O
while O O
consistent O O
with O O
the O O
limited O O
data O O
( O O
n O O
= O O
1 O O
; O O
see O O
Discussion O O
) O O
for O O
Ivory B B_SPECIES[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_SPECIES[BIO]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
is O O
equally O O
consistent O O
with O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
Woodpecker I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
in O O
its O O
initial O O
escape O O
flight O O
. O O

It O O
remains O O
possible O O
that O O
the O O
flight O O
pattern O O
of O O
the O O
bird O O
in O O
the O O
Luneau O O
video O O
is O O
unusual O O
for O O
Pileated B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
but O O
a O O
frequency O O
of O O
8 O O
. O O
6 O O
s O O
- O O
1 O O
is O O
consistent O O
with O O
a O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
Woodpecker I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
gaining O O
initial O O
speed O O
and O O
height O O
in O O
escape O O
flight O O
, O O
and O O
by O O
itself O O
cannot O O
be O O
taken O O
as O O
strong O O
evidence O O
that O O
the O O
Luneau O O
video O O
bird O O
was O O
an O O
Ivory B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

The O O
black O O
trailing O O
edge O O
to O O
the O O
underwing O O
of O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
Woodpecker I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_BODY_PART_OR_ORGAN_COMPONENT
is O O
often O O
very O O
inconspicuous O O
and O O
may O O
disappear O O
completely O O
. O O

In O O
many O O
frames O O
of O O
Pileated B B_ENT/B_LOCATION
Woodpecker I I_ENT/I_LOCATION
, O O
a O O
black O O
trailing O O
edge O O
to O O
the O O
wing O O
is O O
discernable O O
( O O
though O O
due O O
to O O
bleeding O O
of O O
white O O
as O O
a O O
video O O
artifact O O
, O O
it O O
appears O O
narrower O O
than O O
it O O
really O O
is O O
) O O
. O O

Evidence O O
is O O
presented O O
here O O
to O O
show O O
that O O
the O O
distinctive O O
plumage O O
features O O
of O O
Pileated B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
are O O
surprisingly O O
difficult O O
to O O
resolve O O
in O O
poor O O
- O O
quality O O
video O O
of O O
birds O O
in O O
escape O O
flight O O
away O O
from O O
the O O
camera O O
, O O
and O O
that O O
they O O
can O O
show O O
apparent O O
plumage O O
patterns O O
that O O
might O O
more O O
readily O O
be O O
associated O O
with O O
Ivory B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

It O O
is O O
, O O
however O O
, O O
suggested O O
here O O
that O O
critical O O
frames O O
used O O
for O O
identification O O
of O O
the O O
Luneau O O
video O O
woodpecker O O
as O O
an O O
Ivory B B_BIO/B_PERSON
- I I_BIO/I_PERSON
billed I I_BIO/I_PERSON
Woodpecker I I_BIO/I_PERSON
are O O
also O O
consistent O O
with O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
Woodpecker I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_TIME[MEASURE]
. O O

The O O
wingbeat O O
frequency O O
of O O
the O O
bird O O
in O O
the O O
Luneau O O
video O O
is O O
also O O
perhaps O O
consistent O O
with O O
Pileated B B_MEASURE/B_LOCATION
Woodpecker I I_MEASURE/I_LOCATION
, O O
at O O
least O O
for O O
short O O
periods O O
of O O
flight O O
. O O

This O O
analysis O O
has O O
shown O O
that O O
the O O
hypothesis O O
presented O O
in O O
Sibley O O
et O O
al O O
[ O O
4 O O
] O O
is O O
plausible O O
, O O
i O O
. O O
e O O
. O O
that O O
some O O
of O O
the O O
frames O O
interpreted O O
by O O
[ O O
1 O O
] O O
to O O
show O O
the O O
upperwing O O
of O O
an O O
Ivory B B_BIO/B_LOCATION
- I I_BIO/I_LOCATION
billed I I_BIO/I_LOCATION
Woodpecker I I_BIO/I_LOCATION
may O O
in O O
fact O O
show O O
large O O
amounts O O
of O O
white O O
and O O
the O O
black O O
trailing O O
edge O O
from O O
the O O
underwing O O
of O O
a O O
Pileated B B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

' O O
Reenactment O O
of O O
the O O
scene O O
using O O
life O O
- O O
sized O O
, O O
realistically O O
painted O O
, O O
dynamically O O
flapping O O
models O O
produced O O
images O O
remarkably O O
similar O O
to O O
those O O
of O O
the O O
Luneau O O
video O O
using O O
the O O
Ivory B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
model O O
, O O
and O O
images O O
clearly O O
identifiable O O
as O O
Pileated B B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
Woodpecker I I_DISEASE_ADJECTIVE[DISEASE]/I_LOCATION
using O O
a O O
model O O
of O O
that O O
species O O
. O O
' O O

Reenactment O O
of O O
the O O
scene O O
using O O
real O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
Woodpeckers I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ENT
has O O
produced O O
images O O
remarkably O O
similar O O
to O O
the O O
Luneau O O
video O O
. O O

Birds O O
flap O O
more O O
rapidly O O
at O O
take O O
off O O
to O O
gain O O
altitude O O
and O O
speed O O
than O O
they O O
do O O
in O O
sustained O O
level O O
flight O O
: O O
Pileated B B_TIME[MEASURE]/B_LOCATION
Woodpecker I I_TIME[MEASURE]/I_LOCATION
flight O O
data O O
in O O
the O O
literature O O
[ O O
1 O O
, O O
4 O O
, O O
5 O O
] O O
was O O
derived O O
from O O
the O O
work O O
of O O
Tobalske O O
[ O O
8 O O
] O O
, O O
which O O
explicitly O O
excluded O O
the O O
initial O O
take O O
- O O
off O O
period O O
, O O
and O O
therefore O O
cannot O O
be O O
used O O
to O O
support O O
the O O
elimination O O
of O O
Pileated B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
the O O
Luneau O O
video O O
. O O

( O O
8 O O
) O O
' O O
The O O
distance O O
between O O
the O O
wrist O O
area O O
and O O
the O O
tip O O
of O O
the O O
tail O O
( O O
32 O O
- O O
36 O O
cm O O
, O O
as O O
measured O O
when O O
the O O
bird O O
begins O O
to O O
take O O
flight O O
) O O
is O O
comparable O O
to O O
known O O
measurements O O
of O O
Ivory B B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
considerably O O
larger O O
than O O
even O O
the O O
largest O O
Pileated B B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
we O O
measured O O
. O O
' O O

Central O O
to O O
the O O
identification O O
of O O
the O O
flying O O
bird O O
seen O O
in O O
the O O
Luneau O O
video O O
was O O
the O O
evidence O O
that O O
plumage O O
and O O
flight O O
patterns O O
were O O
inconsistent O O
with O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
Woodpecker I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
. O O

A O O
clear O O
photograph O O
will O O
be O O
required O O
from O O
this O O
location O O
too O O
before O O
the O O
presence O O
of O O
Ivory B B_DISEASE
- I I_DISEASE
billed I I_DISEASE
Woodpeckers I I_DISEASE
can O O
be O O
considered O O
confirmed O O
. O O

Flight O O
and O O
plumage O O
patterns O O
of O O
the O O
putative O O
Ivory B B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
billed I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
Woodpecker I I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
recorded O O
in O O
Arkansas O O
in O O
2005 O O
are O O
recapitulated O O
by O O
confirmed O O
Pileated B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
Woodpeckers I I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
. O O

Vibrionaceae O B_BACTERIUM[BIO]/B_PERSON
represent O O
a O O
significant O B_MEASURE/B_PERSON
portion O I_MEASURE/I_PERSON
of O O
the O O
cultivable O B_BACTERIUM[BIO]/B_LOCATION
heterotrophic O B_BACTERIUM[BIO]/I_LOCATION
sea O B_BACTERIUM[BIO]/I_LOCATION
bacteria O B_BACTERIUM[BIO]/I_LOCATION
; O O
they O O
strongly O O
affect O O
nutrient O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
cycling O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
some O O
species O B_BIO/B_PERSON
are O O
devastating O B_DISEASE_ADJECTIVE[DISEASE]
pathogens O I_DISEASE_ADJECTIVE[DISEASE]
. O O

Phage O B_GENE
DNA O I_GENE
is O O
thought O O
to O O
be O O
one O B_NUMBER[MEASURE]/B_LOCATION
of O O
the O O
main O B_LOCATION/B_PERSON
vectors O I_LOCATION/I_PERSON
for O O
lateral O B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
gene O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
transfer O I_DISEASE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
among O O
bacteria O B_BACTERIUM[BIO]
[ O O
1 O B_MEASURE/B_LOCATION
] O I_MEASURE/I_LOCATION
and O O
many O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE
virulence O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
factors O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE
from O O
bacterial O B_BACTERIUM[BIO]/B_PERSON
pathogen O I_BACTERIUM[BIO]/I_PERSON
are O O
phage O B_BACTERIUM[BIO]/B_TIME[MEASURE]
encoded O O
[ O O
2 O B_MEASURE/B_GENE
] O I_MEASURE/I_GENE
. O O

These O O
bacteria O B_BIO/B_PERSON
belong O O
to O O
the O O
Gammaproteobacteria O B_BACTERIUM[BIO]/B_MEASURE
group O I_BACTERIUM[BIO]/I_MEASURE
and O O
are O O
highly O O
abundant O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
in O O
aquatic O B_LOCATION/B_BIO
environment O I_LOCATION/I_BIO
, O O
they O O
strongly O O
influence O O
nutrient O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
cycling O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
and O O
various O B_TIME[MEASURE]/B_ENT
species O I_TIME[MEASURE]/I_ENT
are O O
also O O
devastating O B_DISEASE_ADJECTIVE[DISEASE]
pathogens O I_DISEASE_ADJECTIVE[DISEASE]
. O O

In O O
particular O B_DISEASE_ADJECTIVE[DISEASE]/B_BIO
Altermonadales O I_DISEASE_ADJECTIVE[DISEASE]/I_BIO
, O O
Enterobacteriales O B_BACTERIUM[BIO]
and O O
Burkholderiales O B_BACTERIUM[BIO]
are O O
closely O O
related O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
to O O
Vibrionaceae O B_BACTERIUM[BIO]/B_PERSON
, O O
and O O
share O O
the O O
higher O B_MEASURE/B_LOCATION
number O I_MEASURE/I_LOCATION
of O O
cluster O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
genes O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
average O B_MEASURE/B_LOCATION
percentage O I_MEASURE/I_LOCATION
of O O
20 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
% O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
) O O
. O O

This O O
could O O
be O O
considered O O
as O O
a O O
sort O B_MEASURE/B_LOCATION
of O O
" O O
minimal O B_MEASURE/B_BIO
genome O B_MEASURE/I_BIO
" O O
containing O O
the O O
group O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
that O O
are O O
necessary O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
maintain O O
a O O
free O B_TIME[MEASURE]/B_LOCATION
- O O
living O B_BACTERIUM[BIO]/B_LOCATION
organism O I_BACTERIUM[BIO]/I_LOCATION
. O O

The O O
second O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_SEQUENCE[MEASURE]
group O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_SEQUENCE[MEASURE]
( O O
Fig O B_MEASURE/B_PROTEIN[GENE]
3 O I_MEASURE/I_PROTEIN[GENE]
, O O
panel O B_MEASURE/B_LOCATION
C O I_MEASURE/I_LOCATION
) O O
represents O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
shared O O
mainly O O
among O O
Vibrionaceae O B_BACTERIUM[BIO]
and O O
other O B_BACTERIUM[BIO]/B_PERSON
gamma O I_BACTERIUM[BIO]/I_PERSON
proteobacteria O I_BACTERIUM[BIO]/I_PERSON
( O O
as O O
Altermonadales O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
, O O
Burkholderiales O B_BACTERIUM[BIO]
and O O
Enterobactidiales O B_BACTERIUM[BIO]
) O O
. O O

In O O
particular O B_MEASURE/B_DISEASE_ADJECTIVE[DISEASE]
cluster O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
10 O I_MEASURE/I_DISEASE_ADJECTIVE[DISEASE]
is O O
composed O O
by O O
the O O
core O B_GENE/B_BIO
genes O I_GENE/I_BIO
described O O
before O O
having O O
an O O
high O B_MEASURE
value O I_MEASURE
of O O
similarity O B_MEASURE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
widespread O I_MEASURE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
among O O
all O O
the O O
organisms O B_BIO/B_PERSON
; O O
cluster O B_NUMBER[MEASURE]
8 O I_NUMBER[MEASURE]
contains O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
shared O O
mainly O O
by O O
gamma O B_BACTERIUM[BIO]
proteobacteria O I_BACTERIUM[BIO]
and O O
cluster O B_TIME[MEASURE]/B_LOCATION
14 O I_TIME[MEASURE]/I_LOCATION
is O O
composed O O
of O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
common O B_LOCATION/B_DISEASE_ADJECTIVE[DISEASE]
between O O
Vibrionaceae O B_BACTERIUM[BIO]
and O O
Enterobacteriaceae O B_BACTERIUM[BIO]
. O O

The O O
type O B_GENE/B_BODY_PART_OR_ORGAN_COMPONENT
II O B_GENE/I_BODY_PART_OR_ORGAN_COMPONENT
pathway O B_GENE/I_BODY_PART_OR_ORGAN_COMPONENT
is O O
conserved O O
among O O
gram O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
negative O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
bacteria O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
, O O
including O O
many O B_BACTERIUM[BIO]
pathogens O I_BACTERIUM[BIO]
, O O
and O O
secretes O O
a O O
variety O B_ENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
virulence O B_DISEASE_ADJECTIVE[DISEASE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
factors O B_DISEASE_ADJECTIVE[DISEASE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
and O O
degradative O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
enzymes O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
[ O O
15 O B_SPECIES[BIO]/B_LOCATION
] O I_SPECIES[BIO]/I_LOCATION
. O O

The O O
first O O
group O O
of O O
genes O O
is O O
shared O O
between O O
Photobacterium B B_BACTERIUM[BIO]
profundum I I_BACTERIUM[BIO]
SS9 I I_BACTERIUM[BIO]
and O O
Photobacterium B B_BACTERIUM[BIO]/B_PROTEIN[GENE]
profundum I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
3TCK I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
, O O
while O O
the O O
second O O
is O O
shared O O
between O O
V B B_BACTERIUM[BIO]/B_PROTEIN[GENE]
. I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
vulnificus I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
CMCP6 I B_BACTERIUM[BIO]/I_PROTEIN[GENE]
and O O
YJ016 B B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Indeed O O
, O O
numerous O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
virulence O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
factors O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
from O O
bacterial O B_BACTERIUM[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
pathogens O I_BACTERIUM[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
are O O
phage O B_BACTERIUM[BIO]/B_LOCATION
encoded O O
. O O

In O O
particular O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
we O O
found O O
, O O
1 O B_TIME[MEASURE]
) O O
a O O
set O B_GENE/B_LOCATION
of O O
conserved O B_GENE/B_BIO
genes O I_GENE/I_BIO
( O O
with O O
a O O
high O B_MEASURE/B_LOCATION
similarity O I_MEASURE/I_LOCATION
values O I_MEASURE/I_LOCATION
across O O
all O O
organisms O B_BIO/B_GENE
) O O
that O O
reflects O O
the O O
" O B_BIO/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
minimal O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
genome O I_BIO/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
" O O
composition O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_TIME[MEASURE]
defined O O
in O O
other O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
previous O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
works O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
; O O
2 O B_NUMBER[MEASURE]
) O O
a O O
set O B_PROTEIN[GENE]/B_LOCATION
of O O
genes O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
mainly O O
shared O O
by O O
Vibrionaceae O B_BACTERIUM[BIO]
and O O
other O B_SPECIES[BIO]
Gamma O I_SPECIES[BIO]
proteobacteria O I_SPECIES[BIO]
and O O
3 O B_NUMBER[MEASURE]
) O O
genes O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
specific O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
to O O
different O B_PERSON/B_DISEASE_ADJECTIVE[DISEASE]
sets O I_PERSON/I_DISEASE_ADJECTIVE[DISEASE]
of O O
Vibrionaceae O B_BIO/B_GENE
. O O

C B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE_ADJECTIVE[DISEASE]
. I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
quiquefasciatusshowed I B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_DISEASE_ADJECTIVE[DISEASE]
high O O
sequence O O
( O O
98 O O
- O O
100 O O
% O O
) O O
and O O
RNA O O
secondary O O
structure O O
similarity O O
. O O

Culex O B_BACTERIUM[BIO]/B_PERSON
mosquito O I_BACTERIUM[BIO]/I_PERSON
species O I_BACTERIUM[BIO]/I_PERSON
have O O
been O O
described O O
from O O
a O O
wide O B_MEASURE/B_LOCATION
range O I_MEASURE/I_LOCATION
of O O
environments O B_LOCATION/B_BIO
and O O
are O O
involved O O
in O O
pathogen O B_DISEASE/B_SPECIES[BIO]
transmission O B_DISEASE/I_SPECIES[BIO]
from O O

( O O
Africa O O
) O O
, O O
C B B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. I I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
tarsalis I I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
Italy O O
) O O
, O O
C B B_PERSON/B_LOCATION
. I I_PERSON/I_LOCATION
annulus I I_PERSON/I_LOCATION
( O O
China O O
) O O
, O O
C B B_BIO/B_LOCATION
. I B_BIO/I_LOCATION
pseudovishnui I B_BIO/I_LOCATION

- O O
148 O O
. O O
23 O O
Kcal O O
) O O
followed O O
by O O
C B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_LOCATION
. I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
tarsalis I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_LOCATION
( O O
- O O
129 O O
. O O
2 O O
) O O
, O O
C B B_TIME[MEASURE]/B_DISEASE_ADJECTIVE[DISEASE]
. I I_TIME[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
annulus I I_TIME[MEASURE]/I_DISEASE_ADJECTIVE[DISEASE]
and O O
then O O
by O O
C B B_LOCATION/B_BIO
. I I_LOCATION/I_BIO
vishnui I I_LOCATION/I_BIO

annulus O O
and O O
C B B_BODY_PART_OR_ORGAN_COMPONENT/B_BIO
. I I_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
vishnui I I_BODY_PART_OR_ORGAN_COMPONENT/I_BIO
as O O
well O O
as O O
C B B_BIO/B_BODY_PART_OR_ORGAN_COMPONENT
. I B_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
quinquefasciatus I B_BIO/I_BODY_PART_OR_ORGAN_COMPONENT
and O O
C B B_DISEASE/B_LOCATION
. I B_DISEASE/I_LOCATION

( O O
C B B_LOCATION
. I I_LOCATION
annulus I I_LOCATION
, O O
C B B_BACTERIUM[BIO]/B_LOCATION
. I B_BACTERIUM[BIO]/I_LOCATION
pseudovishnui I B_BACTERIUM[BIO]/I_LOCATION
and O O
C B B_BACTERIUM[BIO]/B_LOCATION
. I I_BACTERIUM[BIO]/I_LOCATION
vishnui I I_BACTERIUM[BIO]/I_LOCATION
) O O
isolates O O
( O O
China O O
and O O
Japan O O
) O O
showed O O
high O O
similarity O O

Comparison O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
of O O
ITS2 O B_GENE/B_BIO
sequences O I_BIO
from O O
different O B_BIO/B_DISEASE_ADJECTIVE[DISEASE]
isolates O I_BIO/I_DISEASE_ADJECTIVE[DISEASE]
of O O
Culex O B_BACTERIUM[BIO]
show O O
similarity O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
and O O
variations O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

This O O
mode O O
of O O
administration O O
favours O O
the O O
anti O O
- O O
inflammatory O O
effects O O
of O O
rAPC O O
, O O
which O O
are O O
particularly O O
efficient O O
in O O
murine B B_DISEASE
models O O
in O O
protecting O O
the O O
endothelium O O
from O O
cytokine O O
- O O
mediated O O
apoptosis O O
or O O
upregulation O O
of O O
endothelial O O
adhesion O O
molecules O O
. O O

Double O O
- O O
stranded O O
cDNA O O
was O O
synthesized O O
from O O
total O O
RNA O O
( O O
separately O O
) O O
from O O
each O O
stage O O
or O O
sex O O
of O O
A B B_BODY_PART_OR_ORGAN_COMPONENT/B_ORGANISM_FUNCTION
. I I_BODY_PART_OR_ORGAN_COMPONENT/I_ORGANISM_FUNCTION
suum I I_BODY_PART_OR_ORGAN_COMPONENT/I_ORGANISM_FUNCTION
using O O
reverse O O
transcriptase O O
( O O
Superscript O O
III O O
, O O
Invitrogen O O
) O O
. O O

Accordingly O O
, O O
genes O O
encoding O O
a O O
specialized O O
tubulin O O
expressed O O
in O O
mechanoreceptors O O
( O O
mec O O
- O O
12 O O
, O O
EST O O
code O O
13E09 O O
) O O
and O O
a O O
troponin O O
( O O
mup O O
- O O
2 O O
, O O
EST O O
code O O
01G03 O O
; O O
see O O
Table O O
2 O O
) O O
, O O
both O O
predicted O O
to O O
interact O O
with O O
a O O
total O O
number O O
of O O
32 O O
tubulin O O
- O O
and O O
myosin O O
- O O
encoding O O
genes O O
, O O
also O O
supported O O
a O O
link O O
to O O
extensive O O
muscle O O
contraction O O
and O O
motility O O
in O O
A B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
. I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
suum I B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
L3s O O
. O O

In O O
conclusion O O
, O O
this O O
study O O
has O O
given O O
some O O
interesting O O
insights O O
into O O
early O O
molecular O O
processes O O
in O O
the O O
L3 O O
of O O
A B B_DISEASE
. I I_DISEASE
suum I I_DISEASE
. O O

For O O
all O O
mouse B B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
studies O O
, O O
minocycline O O
( O O
Sigma O O
, O O
St O O
. O O
Louis O O
, O O
MO O O
) O O
was O O
dissolved O O
in O O
sterile O O
water O O
and O O
sonicated O O
to O O
ensure O O
complete O O
solubilization O O
. O O

In O O
the O O
first O O
mouse B B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
study O O
, O O
adult O O
male O O
BALB O O
/ O O
c O O
mice B B_SPECIES[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
received O O
an O O
intraperitoneal O O
( O O
i O O
. O O
p O O
. O O
) O O
injection O O
of O O
vehicle O O
or O O
minocycline O O
( O O
50 O O
mg O O
/ O O
kg O O
) O O
for O O
three O O
consecutive O O
days O O
. O O

It O O
is O O
important O O
to O O
note O O
that O O
IDO O O
mRNA O O
was O O
undetected O O
in O O
saline O O
treated O O
mice B B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BODY_PART_OR_ORGAN_COMPONENT
. O O

Furthermore O O
, O O
minocycline O O
pretreatment O O
attenuated O O
LPS O O
- O O
induced O O
TLR2 O O
mRNA O O
levels O O
in O O
both O O
adult O O
and O O
aged O O
mice B B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
( O O
Mino O O
x O O
LPS O O
interaction O O
, O O
F O O
( O O
1 O O
, O O
63 O O
) O O
= O O
9 O O
. O O
02 O O
, O O
P O O
< O O
0 O O
. O O
004 O O
) O O
. O O

PM10 O O
2 O O
. O O
5 O O
% O O
CI O O
97 O O
. O O
5 O O
% O O
CI O O
All O O
persons B B_TIME[MEASURE]/B_DISEASE
1 O O
. O O
89 O O
By O O
concurrent O O
diagnosis O O
Respiratory O O
disease O O
Pneumonia O O
With O O
4 O O
. O O
00 O O
Without O O
1 O O
. O O
51 O O
Cardiovascular O O
disease O O
Conduction O O
disorders O O
With O O
2 O O
. O O
34 O O
Without O O
1 O O
. O O
60 O O
Cardiac O O
dysrhythmias O O
With O O
3 O O
. O O
09 O O
Without O O
1 O O
. O O
43 O O
Congestive O O
heart O O
failure O O
With O O
2 O O
. O O
90 O O
Without O O
1 O O
. O O
39 O O
By O O
previous O O
admissions O O
Respiratory O O
disease O O
Acute O O
respiratory O O
infections O O
With O O
3 O O
. O O
20 O O
Without O O
1 O O
. O O
70 O O
Cardiovascular O O
disease O O
CVD O O
With O O
2 O O
. O O
90 O O
Without O O
1 O O
. O O
18 O O
Congestive O O
heart O O
failure O O
With O O
4 O O
. O O
37 O O
Without O O
1 O O
. O O
14 O O
Within O O
1 O O
year O O
6 O O
. O O
04 O O
0 O O
. O O
80 O O
2 O O
. O O
99 O O

Recently O O
, O O
stillborn O O
Simmental O O
calves B B_DISEASE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
observed O O
having O O
a O O
morphology O O
similar O O
to O O
the O O
arachnomelia O O
syndrome O O
. O O

The O O
first O O
was O O
the O O
presence O O
of O O
a O O
calf B B_DISEASE
that O O
was O O
diagnosed O O
by O O
pathological O O
investigation O O
. O O

The O O
cases O O
of O O
malformed O O
Simmental O O
calves B B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
presented O O
here O O
showed O O
the O O
same O O
morphology O O
described O O
in O O
the O O
arachnomelia O O
syndrome O O
in O O
Brown O O
Swiss O O
[ O O
e O O
. O O
g O O
. O O
[ O O
3 O O
] O O
] O O
, O O
even O O
though O O
there O O
is O O
a O O
certain O O
morphological O O
variation O O
from O O
mild O O
to O O
severe O O
malformations O O
. O O

BS O O
examined O O
the O O
calves B B_BODY_PART_OR_ORGAN_COMPONENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
pathologically O O
. O O

Though O O
the O O
patient B B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
has O O
been O O
markedly O O
improved O O
, O O
it O O
is O O
recognized O O
that O O
the O O
result O O
is O O
not O O
as O O
good O O
as O O
is O O
commonly O O
obtained O O
when O O
patients B B_PERSON/B_DISEASE
with O O
more O O
adequate O O
pulmonary O O
arteries O O
are O O
treated O O
by O O
the O O
conventional O O
anastomosis O O
of O O
a O O
systemic O O
artery O O
to O O
the O O
side O O
of O O
the O O
pulmonary O O
artery O O
. O O

Wild O O
- O O
type O O
Canton O O
- O O
S5 O O
[ O O
57 O O
] O O
flies B B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
were O O
used O O
for O O
electron O O
microscopy O O
. O O

Nrg O O
: O O
Neuroglian O O
; O O
Cora O O
: O O
Coracle O O
; O O
Spec O O
: O O
alpha O O
- O O
and O O
beta O O
- O O
Spectrin O O
; O O
SJ O O
: O O
septate O O
junction O O
; O O
SSJ O O
: O O
smooth O O
septate O O
junction O O
; O O
PSJ O O
: O O
pleated O O
septate O O
junction O O
; O O
ZA O O
: O O
zonal O O
adherens O O
junction O O
; O O
AJ O O
: O O
adherens O O
junction O O
; O O
AECM O O
: O O
apical O O
extracellular O O
matrix O O
; O O
ECM O O
: O O
extracellular O O
matrix O O
; O O
HAJ O O
: O O
hemi O O
- O O
adherens O O
junction O O
; O O
SAJ O O
: O O
spot O O
adherens O O
junction O O
; O O
OA O O
: O O
Octopamine O O
; O O
Hts O O
: O O
Hu O O
- O O
li O O
tai O O
shao O O
; O O
ATP O O
alpha O O
: O O
Na O O
+ O O
pump O O
alpha O O
subunit O O
; O O
Mlp84B O O
: O O
Muscle O O
LIM O O
protein O O
at O O
84B O O
; O O
DLG O O
: O O
Disc O O
Large O O
; O O
HRP O O
: O O
horseradish B B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
peroxidas O O
; O O
UM O O
: O O
unmated O O
; O O
M O O
: O O
mated O O
. O O

Fibroblasts O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE
obtained O O
from O O
p8 O B_GENE
- O O
expressing O O
or O O
p8 O B_GENE
- O O
deficient O B_DISEASE_ADJECTIVE[DISEASE]/B_GENE_EXPRESSION_ADJECTIVE[GENE]
animals O B_DISEASE_ADJECTIVE[DISEASE]/I_GENE_EXPRESSION_ADJECTIVE[GENE]
were O O
transformed O O
with O O
a O O
retroviral O B_VIRUS[BIO]/B_GENE
vector O I_VIRUS[BIO]/I_GENE
expressing O O
both O O
the O O
rasV12 O B_GENE
mutated O O
protein O B_GENE/B_BACTERIUM[BIO]
and O O
the O O
E1A O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
adenoviral O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
oncogene O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

p8 O B_GENE
is O O
silenced O O
in O O
pancreatic O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_DISEASE_ADJECTIVE[DISEASE]
cancer O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
cells O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_DISEASE_ADJECTIVE[DISEASE]
by O O
infection O B_DISEASE/B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE
with O O
a O O
retrovirus O B_VIRUS[BIO]/B_GENE
expressing O O
p8 O O
RNA O B_GENE/B_BIO
in O O
the O O
antisense O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
orientation O I_CELL[BODY_PART_OR_ORGAN_COMPONENT]/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]

We O O
inhibited O O
p8 O O
expression O B_GENE
in O O
both O O
Panc O B_DISEASE/B_PROTEIN[GENE]
- O O
1 O B_NUMBER[MEASURE]
and O O
BxPc O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
3 O B_MEASURE
pancreatic O I_MEASURE
cells O I_MEASURE
by O O
infecting O O
cells O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
with O O
a O O
retrovirus O B_VIRUS[BIO]/B_GENE
expressing O O
the O O
p8 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
asRNA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
( O O
antisense O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
RNA O I_GENE/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
) O O
and O O
carrying O O
the O O
puromycin O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
resistance O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
. O O

As O O
shown O O
in O O
Figure O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
2 O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
p8 O B_GENE
protein O I_GENE
was O O
clearly O O
visible O B_DISEASE_ADJECTIVE[DISEASE]
in O O
both O O
Panc O B_DISEASE
- O O
1 O B_NUMBER[MEASURE]
and O O
BxPc O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
3 O B_MEASURE
pancreatic O I_MEASURE
cells O I_MEASURE
infected O O
with O O
the O O
empty O B_VIRUS[BIO]/B_GENE
retrovirus O B_VIRUS[BIO]/I_GENE
but O O
almost O O
undetectable O B_DISEASE_ADJECTIVE[DISEASE]/B_LOCATION
in O O
cells O B_BIO/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
infected O O
with O O
the O O
retrovirus O B_VIRUS[BIO]/B_GENE
encoding O O
the O O
p8 O B_GENE/B_DISEASE_ADJECTIVE[DISEASE]
asRNA O I_GENE/I_DISEASE_ADJECTIVE[DISEASE]
showed O O
, O O
indicating O O
that O O
our O O
anti O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
- O O
sense O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_VIRUS[BIO]
strategy O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_VIRUS[BIO]
is O O
efficient O B_DISEASE_ADJECTIVE[DISEASE]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
to O O
silence O O
p8 O O
gene O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
expression O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
pancreatic O B_DISEASE_ADJECTIVE[DISEASE]/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cancer O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cells O B_DISEASE_ADJECTIVE[DISEASE]/I_CELL[BODY_PART_OR_ORGAN_COMPONENT]
. O O

Viral O B_VIRUS[BIO]/B_DISEASE_ADJECTIVE[DISEASE]
supernatant O I_VIRUS[BIO]/I_DISEASE_ADJECTIVE[DISEASE]
was O O
used O O
to O O
infect O O
Panc O B_DISEASE/B_PROTEIN[GENE]
- O O
1 O B_NUMBER[MEASURE]
and O O
BxPc O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
- O O
3 O B_MEASURE
pancreatic O I_MEASURE
cells O I_MEASURE
and O O
the O O
population O B_PERSON/B_MEASURE
of O O
p8 O B_GENE
- O O
silenced O O
cells O B_CELL[BODY_PART_OR_ORGAN_COMPONENT]/B_BIO
was O O
isolated O O
by O O
selection O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
in O O
presence O B_LAB_TEST_COMPONENT[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
of O O
puromycin O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_BIO
( O O
1 O B_MEASURE/B_LOCATION
mu O I_MEASURE/I_LOCATION
g O I_MEASURE/I_LOCATION
/ O O
ml O B_MEASURE/B_PERSON
) O O
. O O

After O O
48 O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
hours O I_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
, O O
the O O
medium O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
containing O O
virus O B_VIRUS[BIO]/B_METABOLITE[BODY_PART_OR_ORGAN_COMPONENT]
was O O
filtered O O
( O O
0 O B_MEASURE/B_LOCATION
. O O
45 O B_MEASURE
mu O I_MEASURE
m O I_MEASURE
filter O I_MEASURE
, O O
Millipore O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
) O O
to O O
obtain O O
the O O
viral O B_BIO/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
supernatant O B_BIO/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O

Although O O
more O B_MEASURE
than O O
one O B_NUMBER[MEASURE]/B_LOCATION
vector O I_NUMBER[MEASURE]/I_LOCATION
can O O
be O O
utilized O O
, O O
only O O
a O O
library O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
fragments O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cloned O O
into O O
any O O
single O B_BACTERIUM[BIO]/B_GENE
phage O B_BACTERIUM[BIO]/I_GENE
, O O
phagemid O B_GENE/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
plasmid O B_GENE
vector O I_GENE
is O O
actually O O
required O O
, O O
together O O
with O O
a O O
set O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
tagged O O
oligonucleotide O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
primers O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
. O O
Images O B_ENT/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]

Although O O
more O B_MEASURE
than O O
one O B_NUMBER[MEASURE]/B_LOCATION
vector O I_NUMBER[MEASURE]/I_LOCATION
can O O
be O O
utilized O O
, O O
only O O
a O O
library O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
fragments O B_GENE/B_CELL[BODY_PART_OR_ORGAN_COMPONENT]
cloned O O
into O O
any O O
single O B_MEASURE/B_BACTERIUM[BIO]
phage O I_MEASURE/I_BACTERIUM[BIO]
. O O
phagemid O B_BACTERIUM[BIO]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
or O O
plasmid O B_GENE/B_BIO
vector O I_GENE/I_BIO
is O O
actually O O
required O O
, O O
together O O
with O O
a O O
set O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
tagged O O
oligonucleotide O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
primers O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_GENE
. O O

The O O
community O B_ORGANIZATION/B_LOCATION
of O O
biologists O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
undertaking O O
the O O
sequencing O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_GENE
of O O
representative O B_GENE/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
genomes O I_GENE/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
various O B_DISEASE_ADJECTIVE[DISEASE]/B_MEASURE
free O I_DISEASE_ADJECTIVE[DISEASE]/I_MEASURE
- O O
living O B_BIO/B_LOCATION
organisms O I_BIO/I_LOCATION
, O O
ranging O O
in O O
size O B_MEASURE/B_LOCATION
from O O
Mycoplasma O B_BIO
( O O
800kb O B_MEASURE
) O O
to O O
mammals O B_BACTERIUM[BIO]/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
3 O B_MEASURE/B_SPECIES[BIO]
Gb O I_MEASURE/I_SPECIES[BIO]
) O O
( O O
4 O B_MEASURE
) O O
. O O

The O O
sequence O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
is O O
that O O
of O O
Bluescribe O B_PROTEIN[GENE]/B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
M13 O I_PROTEIN[GENE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
+ O I_PROTEIN[GENE]/I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
( O O
template O B_GENE/B_TIME[MEASURE]
DNA O B_GENE/I_TIME[MEASURE]
obtained O O
by O O
rescue O B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ORGANISM_FUNCTION
with O O
M13K07 O B_BACTERIUM[BIO]/B_PROTEIN[GENE]
helper O B_BACTERIUM[BIO]/I_PROTEIN[GENE]
phage O B_BACTERIUM[BIO]/I_PROTEIN[GENE]
( O O
30 O B_NUMBER[MEASURE]/B_LOCATION
) O O
) O O
, O O
and O O
was O O
determined O O
using O O
the O O
primers O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
UEOIC O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PROTEIN[GENE]
, O O
UPOIC O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]
, O O
UE02C O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
, O O
and O O
UP02C O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_DISEASE
for O O
the O O
T O B_PROTEIN[GENE]/B_LOCATION
, O O
C O B_OTHER/B_PROTEIN[GENE]
, O O
G O B_PROTEIN[GENE]/B_OTHER
and O O
A O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PROTEIN[GENE]

The O O
clones O B_DISEASE/B_GENE
sequenced O O
are O O
: O O
a O O
) O O
Bluescribe O B_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
M13 O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
+ O I_DRUG[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
( O O
obtained O O
by O O
rescue O B_THERAPEUTIC_OR_PREVENTIVE_PROCEDURE/B_DISEASE
with O O
M13K07 O B_BACTERIUM[BIO]/B_GENE
helper O B_BACTERIUM[BIO]/I_GENE
phage O B_BACTERIUM[BIO]/I_GENE
( O O
30 O B_MEASURE
) O O
) O O
and O O
b O O
) O O
an O O
M13 O B_GENE/B_TIME[MEASURE]
recombinant O I_GENE/I_TIME[MEASURE]
clone O I_GENE/I_TIME[MEASURE]
prepared O O
in O O
a O O
microtitre O B_TIME[MEASURE]/B_PRODUCT[OBJECT]
tray O B_TIME[MEASURE]/I_PRODUCT[OBJECT]
( O O
21 O B_MEASURE
) O O
( O O
a O O
kind O B_PERSON
gift O I_PERSON
of O O
Victoria O B_NUMBER[MEASURE]/B_PERSON
Smith O I_NUMBER[MEASURE]/I_PERSON
) O O
. O O

I O O
also O O
thank O O
Victoria O B_PERSON/B_ORGANIZATION
Smith O I_PERSON/I_ORGANIZATION
for O O
the O O
gift O B_MEASURE/B_LAB_PROCEDURE[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
of O O
DNA O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_PERSON
samples O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_PERSON
, O O
Bart O B_PERSON/B_LOCATION
Barrell O I_PERSON/I_LOCATION
for O O
long O B_TIME[MEASURE]/B_LOCATION
- O O
term O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_MEASURE
support O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_MEASURE
, O O
Tom O B_PERSON/B_ORGANIZATION
O O I_PERSON/I_ORGANIZATION
' O I_PERSON/I_ORGANIZATION
Keefe O I_PERSON/I_ORGANIZATION
of O O
Milligen O B_BACTERIUM[BIO]/B_LOCATION
/ O O
Biosearch O B_PERSON/B_ORGANIZATION
for O O
lessons O B_PERSON/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
in O O
multiplexing O O
and O O
Amersham O B_LOCATION/B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
International O I_LOCATION/I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
for O O
the O O
optical O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
density O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
overlays O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]
shown O O
in O O
Figure O B_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/B_ENT
2 O I_STUDY[THERAPEUTIC_OR_PREVENTIVE_PROCEDURE]/I_ENT
. O O

However O O
, O O
there O O
were O O
no O O
cosmids O B_BIO/B_GENE
identified O O
in O O
common O B_DISEASE/B_GENE
from O O
all O O
the O O
hybrids O B_BIO/B_DISEASE
positive O I_BIO/I_DISEASE
with O O
centromere O B_VIRUS[BIO]/B_GENE
sequences O B_VIRUS[BIO]/I_GENE
. O O

Since O O
only O O
27 O O
probes O O
from O O
the O O
X O O
chromosome O O
were O O
used O O
to O O
initially O O
characterize O O
the O O
hybrids O O
and O O
the O O
length O O
of O O
individual O O
human B B_DISEASE/B_GENE
fragments O O
in O O
the O O
irradiation O O
hybrids O O
is O O
about O O
1000 O O
- O O
5000 O O
kb O O
, O O
many O O
regions O O
could O O
have O O
been O O
undetected O O
in O O
the O O
original O O
analysis O O
. O O

